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The sultidopeptide leukotrienes, leukotriene E, (LTE,) and its N-acetyl derivative and 
several o- and /3-oxidized metabolites of LTE,, have been anafyzed by tandem mass 
spectrometry. [M-H]- ions were produced by continuous flow fast atom bombardment, 
and coIlision-induced dissociation of these ions was studied by using a triple quadrupoie 
instrument. The product ion spectra obtained were characteristic of the structure of LTE,, 
and mechanisms of ion formation were investigated by using deuterated compounds. 
/3-Elimination of the peptide portion of LTE, by loss of CO, and ethylene amine leaves the 
C-l carboxyl group ionized in the most abundant fragment ion for LTE, and all metabolites. 
Tandem mass spectrometry of fast atom bombardment-generated anions from W- and 
P-oxidized metabolites of LTE, produced similar ions with only a minor influence of the 
third carboxyi group at the omega terminus evident. Tandem mass spectrometry was used 
to identify unequivocally the presence of unmodified LTE, in a high performance liquid 
chromatography-purified fraction of urine from a normal healthy volunteer after infusion 
with LTE,. (1 Am Sot Mass Spectrom 2991, 2, 314-321) 
S 
uhidopeptide leukotrienes are metabolites of 
arachidonic acid synthesized typically by in- 
flammatory cells such as eosinophils, mono- 
cytes, macrophages, and mast cells. Activation of 5- 
lipoxygenase in these cells leads to production of a 
reactive intermediate leukotriene (LT)A, [l, 21. This 
reactive intermediate is conjugated with the tripeptide 
glutathione to form the first member of the sulh- 
dopeptide leukotrienes, LTC, [3]. LTC, has potent 
biological activities that cause constriction of various 
smooth muscles as well as edema in vascular beds [4]. 
These biological properties support the hypothesis 
that such leukotrienes serve as lipid mediators for 
many inflammatory and acute hypersensitivity reac- 
tions in animals and humans [S] . LTC 4 is known to be 
metabolized via sequential peptide cleavage reactions 
that lead to other biologically active members of the 
sulfidopeptide leukotriene class, LTD, and LTE,, with 
the least active being LTE, [6]. Further metabolism of 
sulhdopeptide leukotrienes is known to take place. 
For example, LTE, is metabohzed by the rodent to 
N-ace@-LTE, [7] as well as w- and /3-oxidized prod- 
ucts of the methyl terminus of the eicosanoid hydro- 
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carbon chain [t?, 91. Recently, human metabolites of 
LTE, excreted into urine were found to include 20- 
COOH-LTE,, 18-COOH-LTE*, 16-COOH-A”-LTE 
16-COOH-LTE 3, and 14COOH-LTE, [lo]. The ident? 
tication and measurement of these metabolites in urine 
may provide an index of in vivo production of sulfi- 
dopeptide leukotrienes. 
The analysis of sulhdopeptide leukotrienes has 
centered around several strategies. Analysis by elec- 
tron ionization mass spectrometry [ 111 and desorption 
chemical ionization mass spectrometry [12] have been 
reported, but extensive fragmentation and/or thermal 
decomposition of the molecule appeared to occur in 
spite of prior derivatization. Specitic chemical degra- 
dation of the sultidopeptide leukotrienes has been 
used to analyze these molecules by gas chromatogra- 
phy/mass spectrometry (GC/MS) [13]. Although the 
GC/MS technique is sensitive, a certain amount of 
structural information is unfortunately lost through 
degradation of the molecule. Direct analysis of these 
molecules has been accomplished with fast atom bom- 
bardment mass spectrometry (FAB/MS) [14]. 
Recently, analysis by tandem mass spectrometry of 
both positive and negative ions generated by FAB of 
several sulhdopeptide leukotrienes was reported [15] 
that provided specific data on the mass spectrometric 
behavior of these complex lipids. Collision-induced 
decomposition of both positive and negative ions of 
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LTC, and LTE, suggested specific decomposition 
pathways for each species. These pathways were sup- 
ported through the use of deuterium-labeled material. 
However, analysis of the w- and @-oxidized metabo- 
lites of LTE, have not been described. All members of 
the sulfidopeptide leukotriene family have at Ieast 
two carboxvlic acid moieties and can readily localize a 
(4:l:0.1; v/v/v). This solvent system was used as +e 
flowing FAB mobile-phase during the analysis of 
(N, CJ-‘H,)-LTE, to prevent back-exchange of 
deuterons. Analysis by flowing FAB revealed an ion 
at m/z 442 [M-*HI-, indicating formation of (N, O- 
‘H&LTE,. 
d I 
negative charge as a carboxylate anion. Our work is 
focused on studies of the decomposition of the abun- 
dant negative ions generated by FAB/MS of LTE, and 
its metabolites. 
Methods 
Materials. LTE, and N-acetyl-LTE, were obtained 
from Cayman Chemical (Ann Arbor, MI). Synthetic 
(20-2HS)-LTE4 was obtained from Biomol Laboratories 
(Philadelphia, PA). 20-COOH-LTE,, 18-COOH-LTE4, 
and l&COOH-LTE, were obtained from Oxford 
Chemicals (Ann Arbor, MI). Each of these synthetic 
materials was purified by reverse phase high perfor- 
mance liquid chromatography (I-PLC) by using an 
isocratic methanol/water system at pH 6 with 0.02% 
acetic acid. The content of methanol was adjusted to 
55%, 45%, and 30% for each of the three w-oxidized 
LTE, metabolites, respectively. (O-2H,)-glycerol (98 
atom % excess) was obtained from Aldrich Chemical 
Company (Milwaukee, WI). [35S]LTC4 was prepared 
by transcellular biosynthesis from LTA, by using 
[35S]glutathione-labeled platelets as previously de- 
scribed [lo]. Briefly, platelets were incubated for 3 h 
with 1 mCi of L-[35S]cysteine then incubated with the 
free acid of LTA, (10 PM) for 30 min at 37 “C. At the 
end of incubation, y-glutamyltranspeptidase and 
leucine aminopeptidase were added to cleave the glu- 
tathione residue of LTC, to cysteine (LTE,). The su- 
pernatant fraction was purified by reverse phase HPLC 
to collect [35S]LTE,. 
Mass spectrometry. Continuous flow FAB/MS (CF- 
FAB/MS) was carried out on a Finnigan TSQ70 (San 
Jose, CA) by using the commercial ion source .and 
saddle field-type ion gun. Xenon was used as particle 
source with the gun operated at 1 mA and 7-8 kV. 
Argon was used in the collision region with the offset 
potential of the second quadrupole at 20-30 eV. The 
pressure of argon in this second quadrupole field was 
adjusted to approximately 0.5 mtorr, which caused a 
50% drop in the intensity of the ion at m/z 275 from 
the glycerol matrix. The matrix employed for CF- 
FAB/MS was methanol/water/glycerol (4:l:O.l) at 6 
pL/min. The ion source was maintained at 30 “C and 
the manifold of the mass spectrometer at 50 “C. The 
spectra were obtained by using the Finnigan data 
system. Typically six to ten scans were obtained dur- 
ing the elution of the sulhdopeptide Leukotriene fol- 
lowing injection (1 hL) through a Rheodyne 7520 
injector (Berkeley, CA). The spectra obtained were 
averaged and background subtracted with an aver- 
aged background spectrum. 
Preparafion of N-acefyl derivatives. N-acetyl derivatives 
of LTE,, LTD,, LTC,, 20-COOH-LTE q, 18-COOH- 
LTE,, and 16-COOH-LTE, were prepared by dissolv- 
ing the corresponding nonacetylated compounds (2 
wg) in 150 FL of ethanol followed by treatment with 
150 pL NaHCO, (80 mM), 150 pL triethylamine (80 
n&l), and 10 pL acetic anhydride (10% in acetonitrile). 
The reaction was allowed to proceed for 30 min at 4 
‘C; after addition of 2 mL of water, the N-acetylated 
compounds were extracted using a C-18 solid-phase 
extraction cartridge and purified by reverse-phase 
HPLC by using the same system used for nonacety- 
kated compounds. 
Preparation of (N, 0%,)-LTE,. LTE, contains five 
protons that readily exchange protons with water and 
protic solvents. (N, 0-2H,)-LTE4 was prepared by 
dissolving LTE, (1 pg) in 20 PL of a solvent system 
composed of CH,O*H, ‘Hz0 and (O-2H,)-glycerol 
infusion of lab&d LTE,. Biosynthetically prepared 
[35S]LTE, was infused into one human subject in a 
protocol approved by the Human Research Commit- 
tee (University of Colorado Health Sciences Center) as 
previously described [lo]. Briefly, [35S]LTE, (4 PCi, 45 
pg) was infused in the right hand dorsal digital vein 
over a IO-min period through a 0.22 fi Millex sterile 
filter (Millipore, Bedford, MA). Urine samples were 
collected at 2, 5, 8, 15, and 24 h after infusion. Details 
concerning the recovery of radiolabeled metabolites in 
urine are discussed elsewhere [lo]. Approximately 
75% of that radioactivity eliminated in urine during 
the first 2 h following the beginning of the infusion of 
[%S]LTE, was retained on a XAD-8 column after acidi- 
fication of urine to pH 4 with formic acid. After 
washing the column with 200 mL of water, the ra- 
dioactivity was eluted with 200 mL of methanol. This 
methanol eluate was dried under reduced pressure 
and reconstituted in 15% methanol/water and in- 
jected onto reverse-phase HPLC column (Ultrasphere 
ODS, 4 am, 0.46 x 25 cm, Beckman, San Ramon, 
CA) by using a linear gradient from 16 mM ammo- 
nium formate adjusted to pH 4.8 with HCl to 
methanol/water/acetic acid (90:10:0.1, v/v/v) over 55 
min. The majority of the radioactivity eluted from the 
column between 60 and 62 min as a single large peak 
[lo]. The HPLC fraction coIlected during this period 
was concentrated at reduced pressure and reconsti- 
tuted in a small volume (10 pL) for FAB/MS. 
316 SALA ET AL J Am Sot Mass Spectrom 1991, 2, 314-321 
In preliminary studies with commercially available 
[3H]LTE4, it was found that LTE, was stable in urine 
for periods up to several hours at 37 ‘C and for 
several months at -20 “C in methanol/water solu- 
tions. However, this urine sample was immediately 
purified by XAD-8 extraction following collection to 
minimize any decomposition. 
Results 
Collision-induced dissociation of LTE,. Low energy col- 
lision-induced dissociation (CID) of the abundant [M- 
HI- ions from the FAB of LTE, produced a wealth of 
fragment ions (Figure 1A). The most abundant masses 
observed were identical to those previously reported 
for the decomposition of LTE, in a tandem hybrid 
mass spectrometer [15]. Two isotopically labeled vari- 
ants were available to probe ion structures which 
either had deuterons at each of the exchangeable 
proton positions (Figure 1B) or a perdeuterated methyl 
terminus (Figure 1C). Collision-induced dissociation 
of m/z 438 from LTE, [M-H]- results in the appear- 
ance of several abundant ions. The ion at m/r 
420 is most likely a remote-site loss of a neutral 
molecule of water from the hydroxyl moiety at C-5. 
The most abundant ions appear to be formed follow- 
ing charge-driven processes with localization of the 
anionic site either on the C-l carboxyl group or the 
cysteinyl carboxyl moiety. Several mechanisms can be 
drawn to rationalize the observed data that are a 
consequence of various sites of anion localization for 
the ion at m/z 438. However, considering the zwitter- 
ionic nature of a-amino acids in solution, one likely 
gas-phase negative ion species could, in fact, have 
three ionic sites that could decompose by p-elimina- 
tion to structure A_ (Scheme I). The second mecha- 
nism illustrated involves a proton rearrangement in a 
favored six-membered ring remote from an ionized 
carboxyl moiety at C-l. Either process outlined in 
Scheme I involves a @-elimination mechanism with 
loss of two neutral species, ethylene amine and CO, 
(loss of 87 u) (A_, m/z 351). The facile nature of these 
decomposition reactions may be due, in part, to the 
loss of the small neutral species as well as the stability 
of the carboxylate anion. Subsequent loss of water 
from this ion (A) yieIded another abundant ion at 
m/r 333 (l3), as shown in Scheme II. The abundant 
ion at m /z 235 (Q could arise from a charge-driven 
cleavage of the 5,6 bond in the arachidonate backbone 
of ion structure A_ leaving the anionic site located on 
the carbon atom allylic to the conjugated triene (G 
Scheme II). It is of interest that this ion was not 
observed in the previous study that used the tandem 
hybrid mass spectrometer [15]. When deuterium was 
incorporated into the exchangeable positions on OH, 
NH,, and COOH, m/z 235 was shifted to m/z 234, 
supporting migration of a single exchangeable proton 
to the sulfur atom. This ion retains the alkyl chain of 
Figure 1. Fast atom bombardment mass spectrometry and col- 
lision-induced dissociation of the [M-H]- anions from (a) 
leukotriene (LT) E, at m/z 438; (b) N,O-‘H,)-LTE, at m/z 442; 
and (c) (2Ck2H,)-LTE, at m/z 441. The CID was performed by 
using argon in the collision quadrupole region at 20 eV collision 
energy (laboratory frame of reference). 
OR 
[M-HI - 
m/z 438 
Scheme I 
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Scheme II 
LTE, as evidenced by shifting to m/z 238 in (ZO-‘H3)- 
LTE, (Figure 1C). A precursor scan of m/z 235 indi- 
cated that only m/z 351 and m/z 438 decompose to 
form this ion (Table 1). The abundant ion at m/z 333 
(B) loses 44 mass units, again loss of COZ, to form the 
ion at m/z 289 (D) (Scheme II). This was supported 
by precursor scan data (Table 1). The abundance of 
this ion may be related to the stability of the thiolate 
anion and delocahzation of electrons over a nine atom 
system. A minor ion was observed at m/z 317, which 
would correspond to the loss of H,S from A. This ion 
was also observed at m/z 317 (N, 0-‘Hs)-LTE, (Fig- 
ure 1B) suggesting a triene epoxide structure shown 
in Scheme II, which has lost the exchangeable proton 
at the C-5 hydroxyl. 
The minor ions at m/z 322 (lZ) and 120 (E) corre- 
spond to attack of a carboxylate anion on the proton 
of the C-5 hydroxyl group and the proton at C-5, 
respectively (Schemes III and IV). The stability of the 
product anion at m/z 322 is likely enhanced by facile 
transfer of the site of ionization to the carboxyl group 
(E_‘) and loss of the stable aldehyde. This ion is shifted 
by 3 u in both deuterated species consistent with the 
structures E_ and E’ (Scheme III). From the (AJ, O- 
2Hs)-LTE, study it is clear that the ion at m/z 120 
contains only two deuteriums (m/z 122) from this 
labeled species (Scheme IV), which suggests that the 
Table 1. kecur~~r scan data obtained during negative ion fast 
atom bombardment mass spectrometry tandem of LTE; 
Observed ions (m/z) Precursor ionsb (m/r) 
420 438 
351 @,” 438 
333 @I 438 420 
235 CC_, 438 351 
289 @) 438 420 351 333 
317 438 351 
120 (E) 438 
115GJ 438 351 
‘Precursor scan obtained by using triple quadrupole mass spec- 
trometer. 
‘land observed in the product ion scan of m/z 438 are listed. 
Other ions found in these precursor scans corresponded to glycerol 
adducts. 
CDesignated ion structures shown in Schemes I-V. 
Scheme III 
Scheme IV 
carboxyl proton in structure _F originated from a non- 
deuterated position such as the proton at C-5. This is 
consistent with the spectrum from (20-2Hs)-LTE, 
(Figure 1C) in which m/z 120 is not shifted. The 
stability of this ion may be related to the stability of 
the thiolate anion. 
The ion at m/z 115 (G) is quite interesting in that it 
contains no deuterium% any of the labeled species 
studied (Figure 1B and C). With the anionic site local- 
ized on the C-l carboxyl, this ion could arise from a 
remote site fragmentation process with the proton on 
the hydroxyl at C-5 migrating to C-12, all double 
bonds shifting with cleavage of C-5-6 and formation 
of a carbonyl at C-5 (Scheme V). It could originate 
directly from [M-H]- of LTE, as shown or also from 
m/z 351 based upon precursor scan data. Although 
the abundance of this ion is low, it was observed in 
LTE, species and metabolites (see below). 
Collision-induced dissociation of LTE, metabolites. The 
CIDs of [M-H]- generated by CF-FAB/MS of three 
synthetic metabolites of LTE, are shown in Figure 2. 
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o- - &.,_.coo- 
m/z 116 
m/z 438 
Scheme V 
G 
“H H-H. 
Figure 2. Product ions spectra (tandem mass spectrometry) of 
the [M-H]- anions generated by fast atom bombardment with 
glycerol as matrix. (a) 20-COOH-LTE,, m/z 468; (b) 18-COOH- 
LTE,, m/z 440; and (c) 16.COOH-LTE,, m/z 414. The CID was 
performed by using argon in the collision quadrupole region at 
20-30 eV collision energy (laboratory frame of reference). 
Very similar CID behavior was observed for these 
metabolites. The most abundant fragment ions in 
these decomposition spectra were again related to the 
loss of 87 II as described for LTE, and outlined in 
Scheme I as @-elimination. There was an additional 
series of ions evident in the CID spectra of the three 
rnetabolites studied that involve the loss of H,S from 
ions C_ and Q, previously discussed. With loss of H,S, 
the formation of a conjugated pentaene with the 
charge site localized on the o-carboxylate position 
would result in ion (FI) for the ZO-COOH-LTE4 
metabolite observed at m/z 231 (Scheme VI). The loss 
of H,S from anion Q may result in formation of a 
conjugated hexaene (I) as shown in Scheme VII. As 
indicated, this loss of H,S may be preceded by a 
proton rearrangement to protonate the thiolate anion, 
leaving a stable anion site at C-4 delocaliied over a 
carbon T-system. These ions (I) at m/z 285, 257, and 
231 were observed for each w-carboxy metabolite, 
20-COOH-LTE,, l%COOH-LTE,, and 16COOH- 
LTE,, respectively. 
Collision-induced dissociation of N-ucetyl-LTE, metubolites. 
The metabolism of LTE, in the rat is dominated by 
N-acetylation of the free amino group on the cysteine 
portion of LTE, [7]. The CID mass spectrometry of 
N-acetyl-LTE, has been previously reported [15] and 
follows similar pathways to that described above for 
LTE, except that the acetylation of the amino group 
facilitates charge localization on the cysteine-carboxyl 
group. The mass spectra of N-acetyl-LTC4/D4/E4 as 
well as the metabolites of LTE, observed in the rat, 
20-COOH-N-acetyl-LTE,, 18-COOH-N-acetyl-LTE,, 
and 16COOH-N-acetyl-LTEs are listed in Table 2. 
Similar ions discussed above were observed for the 
N-acetyl-derivatives with the most abundant ion (ex- 
cept for N-acetyl-LTD, and N-acetyl-LTC,) being re- 
lated to the formation of the carboxylate anion (A) 
(Scheme I) and loss of N-acetyl ethylene amine and 
co,. 
Analysis for LTE, in human urine. When [35S]LTE, (45 
rg) was injected into a human subject and urine was 
m/z 255 
C 
-00 2 
Scheme VI 
m/z as5 
I 
Scheme VU 
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collected, a major portion of the radioactivity was 
eliminated into urine within the first collection period 
(2 h) [lo]. Solid phase extraction of the frrst 2 h urine 
collection followed by reverse-phase I-PLC purifica- 
tion resulted in isolation of a component that ab- 
sorbed UV light with a UV maximum at 280 nm and 
shoulder maxima at 270 and 290 nm, typical for the 
conjugated triene chromophore of stidopeptide 
leukofrienes [lo]. From the intensity of the UV ab- 
sorbance (molar extinction coefficient = 40,000) a total 
of no more than 400 ng was present in this fraction. 
CF-FAB/MS analysis of an aliquot of the HPLC 
effluent (10%) at the elution time indicated by the W 
absorption maximum produced the complex mass 
spectrum shown in Figure 3A. En addition to several 
other ions, there was an ion at m-/z 438, suggesting 
the presence of LTE+ Tandem mass spectrometry of 
this peak resulted in abundant product ions at m jz 
235, 333, 351, and 420(Figure 3B). The relative abun- 
dances of these ions were similar to that observed for 
the CID of authentic LTE, (Figure 1A). In addition to 
these ions, several other minor ions, whose structures 
were discussed above, we& also apparent, including 
ions at m/z 115, 120, and 289. The tandem mass 
spectrometry experiment provided unequivocal evi- 
Figure 3. The fast atom bombardment mass spectrum obtained 
from an aliquot of an HFLC-purified fraction of human urine 
collected following the infusion of LTE, into a human sub@. 
(a) Continuous flow-fast atom bombardment mass spectrometry 
analysis of the fraction containing a radioactive and UV absorb- 
ing component corresponding to LTE,, which has an [M-H]- 
anion at m/z 438. (b) Tandem mass spectrometric analysis of 
the suspected [M-H] - anion after collision-induced dissociation 
by using argon at 20 eV collision energy (laboratory frame of 
reference). 
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dence for identification of LTE, eliminated into urine 
by this human subject. 
Discussion 
Cysteine-containing leukotrienes analyzed by 
FAB/MS were shown to undergo facile CID reactions 
in the triple quadrupole mass spectrometer, leading to 
characteristic product ions. In most cases the pro- 
cesses involved in the formation of these product ions 
could be rationalized with a charge-driven mechanism 
from an initial localized charge at the-cysteinyl car- 
boxy1 moiety followed by fi-eliminationor a charge-re- 
mote &elimination reaction if the anionic site were 
localized at the C-l carboxyl moiety. Many CID reac- 
tions appeared to involve attack of the carboxylate 
anion on a heteroatom-bonded proton at several sites 
in the LTE, structure. One typical characteristic of the 
decomposition pathways for these complex carboxyl- 
ate anions was loss of small neutral molecules such as 
CO,, ethylene amine, H,S, and H,O. 
observed using the tandem quadrupole instrument 
were not reported when a hybrid tandem mass spec- 
trometer was used [15]. The basis for such discrepan- 
cies is not known; however, the time-scale for those 
two experiments is somewhat different in terms of 
life-time of the anions as they enter the quadrupole 
collision chamber. 
It is of interest to note that the behavior of LTE, in 
low energy CID mass spectrometry is substantially 
different than that observed for LTC, and LTD, [15], 
possibly due to the influence of the additional amino 
acids in these structures. This suggests that each ion- 
ized group (at the pH of the matrix) greatly influences 
decomposition behavior and, furthermore, hetero- 
geneity with respect to site-of-charge localization may 
exist in the [M-H]- ions. The results presented here 
as well as those previously reported [15] for CID, of 
sulhdopeptide leukotrienes are consistent with the 
cysteinyl leukotrienes decomposing by b-elimination 
to yield abundant thiol carboxylate anions, whereas 
glutathione leukotrienes yield the most abundant ions 
with negative charge retained by the peptide portion 
of the molecule. This behavior was seen with other 
glutathione and cysteinyl conjugates. Deterding et al. 
[16] found that N-acetyl cysteinyl conjugates of xeno- 
biotics produced mostly thiolate anions [RS]- upon 
CID; whereas in negative ion FAB/CID of glutathione 
conjugates, the charge was retained by the glu- 
tathione moiety. Negative ion FAB/CID was used to 
screen for mercapturic acids [RSCH,CH(HNAc) 
COOH] derived from various compounds. Regardless 
of the chemical nature of the conjugate, the dominant 
fragment was the alkyl thioiate anion [RS]- resulting 
from the loss of the amino acid portion [17]. 
Tandem mass spectrometry of urine extracts of a 
human subject injected with LTEl provided strong 
evidence to support the occurrence of LTE, elimi- 
nated into urine, which is consistent with previous 
reports that used HPLC retention time data [7, 10, 
181. Because the amount of LTE4 used for this analysis 
was less than 40 ng, this experiment illustrates the 
power of tandem mass spectrometry and CID/FAB/ 
MS for the analysis of sulfidopeptide leukotrienes in 
physiologic fluids. Although the urine had been puri- 
fied by reverse-phase HPLC, unequivocal identifica- 
tion of this molecule would not be possible based 
upon the appearance of a single ion in the CF-FAB 
mass spectrum. Conclusive evidence for the occur- 
rence of this molecule was obtained through a combi- 
nation of HPLC retention time, UV spectroscopy, and 
mass spectrometric techniques in&ding CF-FAB/MS, 
CID, and tandem mass spectrometry. These results 
suggest the usefulness of this approach in the identi- 
fication of human metabolites of LTE, in urine due to 
the unique behavior of these cysteine derivatives in 
the CID process. 
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